Q15109 [Direct mapping]
Advanced glycosylation end product-specific receptor

GO:0004872 [receptor activity]
GO:0004888 [transmembrane signaling receptor activity]
GO:0005515 [protein binding]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0007166 [cell surface receptor signaling pathway]
GO:0009611 [response to wounding]
GO:0031175 [neuron projection development]
GO:0042802 [identical protein binding]
GO:0044548 [S100 protein binding]
GO:0045087 [innate immune response]
GO:0051092 [positive regulation of NF-kappaB transcription factor activity]

Q15109 [Direct mapping]
Advanced glycosylation end product-specific receptor

GO:0004872 [receptor activity]
GO:0004888 [transmembrane signaling receptor activity]
GO:0005515 [protein binding]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0007166 [cell surface receptor signaling pathway]
GO:0009611 [response to wounding]
GO:0031175 [neuron projection development]
GO:0042802 [identical protein binding]
GO:0044548 [S100 protein binding]
GO:0045087 [innate immune response]
GO:0051092 [positive regulation of NF-kappaB transcription factor activity]

Q5SSZ3 [Direct mapping]
Advanced glycosylation end product-specific receptor

GO:0005515 [protein binding]

Q15109 [Direct mapping]
Advanced glycosylation end product-specific receptor

GO:0001666 [response to hypoxia]
GO:0001933 [negative regulation of protein phosphorylation]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0001937 [negative regulation of endothelial cell proliferation]
GO:0004872 [receptor activity]
GO:0004888 [transmembrane signaling receptor activity]
GO:0005515 [protein binding]
GO:0005576 [extracellular region]
GO:0005615 [extracellular space]
GO:0005737 [cytoplasm]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006954 [inflammatory response]
GO:0007162 [negative regulation of cell adhesion]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007259 [JAK-STAT cascade]
GO:0007420 [brain development]
GO:0008201 [heparin binding]
GO:0009100 [glycoprotein metabolic process]
GO:0009611 [response to wounding]
GO:0009750 [response to fructose]
GO:0009925 [basal plasma membrane]
GO:0009986 [cell surface]
GO:0010508 [positive regulation of autophagy]
GO:0010596 [negative regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0010763 [positive regulation of fibroblast migration]
GO:0014002 [astrocyte development]
GO:0014823 [response to activity]
GO:0014911 [positive regulation of smooth muscle cell migration]
GO:0030324 [lung development]
GO:0030335 [positive regulation of cell migration]
GO:0030424 [axon]
GO:0031175 [neuron projection development]
GO:0032966 [negative regulation of collagen biosynthetic process]
GO:0033189 [response to vitamin A]
GO:0033595 [response to genistein]
GO:0033689 [negative regulation of osteoblast proliferation]
GO:0035690 [cellular response to drug]
GO:0042802 [identical protein binding]
GO:0043025 [neuronal cell body]
GO:0043065 [positive regulation of apoptotic process]
GO:0043507 [positive regulation of JUN kinase activity]
GO:0043525 [positive regulation of neuron apoptotic process]
GO:0044548 [S100 protein binding]
GO:0045087 [innate immune response]
GO:0048146 [positive regulation of fibroblast proliferation]
GO:0048661 [positive regulation of smooth muscle cell proliferation]
GO:0050729 [positive regulation of inflammatory response]
GO:0050785 [advanced glycation end-product receptor activity]
GO:0050930 [induction of positive chemotaxis]
GO:0051092 [positive regulation of NF-kappaB transcription factor activity]
GO:0051101 [regulation of DNA binding]
GO:0051595 [response to methylglyoxal]
GO:0055074 [calcium ion homeostasis]
GO:0055093 [response to hyperoxia]
GO:0060100 [positive regulation of phagocytosis, engulfment]
GO:0060290 [transdifferentiation]
GO:0070301 [cellular response to hydrogen peroxide]
GO:0070379 [high mobility group box 1 binding]
GO:0071333 [cellular response to glucose stimulus]
GO:0071398 [cellular response to fatty acid]
GO:0071407 [cellular response to organic cyclic compound]
GO:0071639 [positive regulation of monocyte chemotactic protein-1 production]
GO:0072657 [protein localization to membrane]
GO:0072714 [response to selenite ion]
GO:1901018 [positive regulation of potassium ion transmembrane transporter activity]
GO:1901216 [positive regulation of neuron death]
GO:1904597 [negative regulation of connective tissue replacement involved in inflammatory response wound healing]
GO:1904599 [advanced glycation end-product binding]
GO:1904604 [negative regulation of advanced glycation end-product receptor activity]
GO:2000353 [positive regulation of endothelial cell apoptotic process]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000676 [positive regulation of type B pancreatic cell apoptotic process]

Q15109 [Direct mapping]
Advanced glycosylation end product-specific receptor

GO:0004872 [receptor activity]
GO:0004888 [transmembrane signaling receptor activity]
GO:0005515 [protein binding]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0007166 [cell surface receptor signaling pathway]
GO:0009611 [response to wounding]
GO:0031175 [neuron projection development]
GO:0042802 [identical protein binding]
GO:0044548 [S100 protein binding]
GO:0045087 [innate immune response]
GO:0051092 [positive regulation of NF-kappaB transcription factor activity]

Q3L1R2 [Direct mapping]
Advanced glycosylation end product-specific receptor; Receptor for advanced glycosylation end-products deletion exon3-10 variant

GO:0005515 [protein binding]
GO:0016021 [integral component of membrane]